MENU

Clinical Trials

A clinical trial is a research study that allows volunteers to receive treatment with a drug or device currently under research testing by a pharmaceutical or biotechnology company. These companies carefully select qualified physicians who serve as "investigators” to lead the study trials.

Arkansas Children's offers opportunities to the community to participate in many studies. Use the search fields below to review the current available studies.

If you have questions about volunteering for research studies, please visit our Frequently Asked Questions page. 

If would like to be contacted about clinical research opportunities, consider joining our Research Registry or sign up to receive text updates on your mobile device.  CLICK HERE to learn more. 

See our currently enrolling studies list.

Title:  
A Multi-center Phase III, Randomized, Open- Label Trial of Vigil (bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in combination with Irinotecan and Temozolomide as a Second-Line Regimen for Ewing’s Sarcoma
Description:  

This is a research study to determine the effectiveness and safety profile of VIGIL in combination with standard relapsed chemotherapy for children and young adults with first relapse of Ewing’s Sarcoma.

Study Eligibility:  
Children who are greater than or equal to 2 years old and with first relapse of Ewing’s Sarcoma may be eligible.
Content Study Link:  
Principal Investigator:  
Category:  
Oncology/Cancer
Contact Information:  
For more information about this study, contact Catherine Redinger at 501-364-4290/RedingerCatherineL@uams.edu or Suzy Hall at 501-364-4181/Hallsf@archildrens.org
Inclusion/Notes: